12:00 AM
Aug 20, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Trichuris suis ova: Phase II started

Coronado began the double-blind, placebo-controlled, U.S. Phase II TRUST-I trial to evaluate 7,500 Trichuris suis ova every 2 weeks for 12 weeks in about 220 patients. The trial includes a 12-week open-label extension. Dr. Falk Pharma is also...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >